Atlas Trials

A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

Clinical trial NCT07140523 · RECRUITING

Trial details

NCT number
NCT07140523
Sponsor
Sirius Therapeutics Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Venous Thromboembolism
Start date
2025-09-16
Primary completion
2026-06-30
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.